Accretion Pharmaceuticals Limited
| Opening Date | Closing Date | Face Value | Issue Price | Lot Size | Listing At | Total Issue Size | Basis of Allotment | Initiation of Refunds | Credit of Shares to Demat | Listing Date |
|---|---|---|---|---|---|---|---|---|---|---|
| 14-05-2025 | 16-05-2025 | ₹10 per share | 0 | 1,200 Shares | NSE SME | 29,46,000 shares (aggregating up to ₹29.75 Cr) | 2028-05-19 00:00:00 | 2025-05-20 00:00:00 | 2025-05-20 00:00:00 | 21-05-2025 |
About The Company
Accretion Pharmaceuticals IPO is a bookbuilding of ₹29.75 crores. The issue is entirely a fresh issue of 29.46 lakh shares.
Accretion Pharmaceuticals IPO opens for subscription on May 14, 2025 and closes on May 16, 2025. The allotment for the Accretion Pharmaceuticals IPO is expected to be finalized on Monday, May 19, 2025. Accretion Pharmaceuticals IPO will be list on NSE SME with a tentative listing date fixed as Wednesday, May 21, 2025.
Accretion Pharmaceuticals IPO price band is set at ₹101 per share. The minimum lot size for an application is 1200. The minimum amount of investment required by retail investors is ₹1,15,200. But it is suggested to the investor to bid at the cutoff price to avoid the oversubscription senerio, which is about to ₹1,21,200. The minimum lot size investment for HNI is 2 lots (2,400 shares) amounting to ₹2,42,400.
Jawa Capital Services Private Limited is the book-running lead manager of the Accretion Pharmaceuticals IPO, while Kfin Technologies Limited is the registrar for the issue.The market maker for Accretion Pharmaceuticals IPO is Gretex Share Broking Private Limited.
Financials
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrow |
|---|---|---|---|---|---|---|
| 31-03-2022 | 18 | 23 | 0 | 3.08 | 0 | 7.61 |
| 31-03-2023 | 21 | 30 | 0 | 0.1 | 0 | 8.47 |
| 31-03-2024 | 27 | 34 | 4 | 3.84 | 1.35 | 13.48 |
| 31-12-2024 | 40 | 36 | 5 | 13.58 | 5.41 | 13.79 |
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1200 | 121200 |
| Retail (Max) | 1 | 1200 | 121200 |
| HNI (Min) | 2 | 2400 | 242000 |
IPO Listing Details
| Listing Date | 21-05-2025 |
| BSE Script Code | - |
| NSE Symbol | - |
| ISIN | - |
| Final Issue Price | 0 |
Promoter holdings
The promoters of the company are Mr. Mayur Popatlal Sojitra, Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel and Mr. Hardik Mukundbhai Prajapati.
Contact Information of the Company
Accretion Pharmaceuticals Limited
29 Xcelon Ind Park 1,
B/h, Intas Pharmaceuticals, Vasna Chacharvad
Sanand,
Phone: +91-97148 82929
Email: compliance@accretionpharma.com
Website: https://accretionpharma.com/
IPO Registrar
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: apl.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
IPO Lead Manager
Jawa Capital Services Private Limited